Free shipping on all orders over $ 500

Nirsevimab

Cat. No. M24872

All AbMole products are for research use only, cannot be used for human consumption.

Nirsevimab Structure
Synonym:

MEDI8897

Size Price Availability
1mg USD 600 3-4 Weeks
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research.

Chemical Information
CAS Number 1989556-22-0
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Susan J Keam. Drugs. Nirsevimab: First Approval

[2] Joseph Domachowske, et al. N Engl J Med. Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity

[3] Laura L Hammitt, et al. N Engl J Med. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

[4] Harrison C Bergeron, et al. Expert Opin Investig Drugs. Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)

[5] M Pamela Griffin, et al. N Engl J Med. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

Related RSV Products
Ribavirin

Ribavirin (ICN-1229) is an antiviral agent used to study severe RSV infections, hepatitis C virus infections, and other viral infections.

Presatovir

Presatovir is a novel, orally bioavailable RSV fusion inhibitor, against a wide range of RSV A and B clinical isolates (mean EC50 = 0.43 nM).

RSV604 (A-60444)

RSV604 (A-60444) is a cell-permeable, non-cytotoxic (CC50 >50 μM) benzodiazepine derivative that is reported to target respiratory syncytial virus (RSV) nucleoprotein (N), with a Kd of 1.6 μM. RSV604 displays submicromolar activity against numerous clinical isolates of both the A and B subtypes of RSV (average EC50s=0.8 μM).

VV116 hydrobromide

VV116 (JT001) hydrobromide is an orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV) infection.

Palivizumab

Palivizumab (MEDI 493) is a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection.

  Catalog
Abmole Inhibitor Catalog




Keywords: Nirsevimab, MEDI8897 supplier, RSV, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.